Esophageal Adenocarcinoma — Trials

Esophageal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 45
Ph III recruiting: 4
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04921904	Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca	completed	Phase 1 / Phase 2	26	Baylor Research InstituteOTHER	1	Sep 14, 2026	clinicaltrials
NCT05411133	Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients	completed	Phase 1	33	Arbele Pty LtdINDUSTRY	2	Mar 19, 2026	clinicaltrials
NCT06549816